Table
of Contents
|
|
|
|
List of Contributors |
xiii |
|
List of Abbreviations |
xv |
PART I |
WHAT IS HEART FAILURE? |
|
1 |
What is Heart Failure? Andrew L. Clark |
3 |
2 |
Heart Failure Syndromes Andrew L. Clark |
8 |
PART II |
EPIDEMIOLOGY |
|
3 |
The Epidemiology of Heart Failure Kaushik Guha and Theresa A. McDonough |
19 |
PART III |
THE AETIOLOGY OF HEART FAILURE |
|
4 |
The Classical Causes of Heart Failure Roy S. Gardner and Colette E. Jackson |
29 |
5 |
The Genetics of Heart Failure Giuseppe Limongelli and Perry M. Elliott |
39 |
6 |
Metabolic Heart Failure |
55 |
7 |
Adult Congenital Heart Disease L. Swan |
70 |
8 |
Infective and Infiltrative Causes of Heart Failure Roy S. Gardner and
Andrew L. Clark |
77 |
9 |
Latrogenic Heart Failure Martin Denvir |
92 |
PART IV |
PATHOPHYSIOLOGY OF HEART FAILURE: CELLULAR AND
MOLECULAR CHANGES |
|
10 |
Intracellular Calcium Handling in Heart Failure Godfrey L. Smith and Rachel C.
Myles |
103 |
11 |
Myocardial Energetics Peter H. Sugden
and Stephen J. Fuller |
110 |
12 |
The Failing Cardiomyocyte Alexander Lyon and |
119 |
PARTV |
PATHOPHYSIOLOGY OF HEART FAILURE |
|
13 |
The Pathophysiology of Heart Failure Theresa A. McDonough and Henry J. Dargie |
133 |
14 |
Cardiac Natriuretic Peptides and Heart Failure Theresa A. McDonough |
144 |
15 |
Vasopressin Benjamin R. Szwejkowski, Sushma Rekhraj, and Allan Struthers |
153 |
16 |
Cytokines and Inflammatory Markers Stamatis Adamopoulos, Panagiota Georgiadou, and Vassilios
Voudris |
157 |
PART VI |
THE DIAGNOSIS OF HEART FAILURE |
|
17 |
Diagnosing Heart Failure Henry J. Dargie
and Theresa A. McDonagh |
171 |
PART VII |
NONINVASIVE INVESTIGATION |
|
18 |
Basic Investigation of Heart Failure Roy S. Gardner |
177 |
19 |
Echocardiography Alison Duncan |
185 |
20 |
Nuclear Medicine in Heart Failure Pushan Bharadwaj and S. Richard Underwood |
203 |
21 |
Heart Failure Imaged by Cardiac Magnetic Resonance Imaging C.
Parsai and S.K. Prasad |
213 |
22 |
CT Imaging Techniques Joanne D. Schuijf, Laurens F.Tops, and Jeroen J. Bax |
225 |
23 |
Metabolic Exercise Testing in Chronic Heart Failure Klaus K. Witte |
232 |
PART VIII |
INVASIVE INVESTIGATION |
|
24 |
Invasive Investigation Roy S. Gardner |
249 |
PART IX |
PROGNOSTICATION |
|
25 |
Prognostication Roy S. Gardner |
265 |
PART X |
COMORBIDITIES: THE PATIENTS WITH HEART
FAILURE AND |
|
26 |
Diastolic Heart Failure Andrew L. Clark |
231 |
27 |
Right Heart Failure Andrew L. Clark |
289 |
28 |
Anaemia Peter Van Der Meer and Dirk J. Van Veldhuisen |
297 |
29 |
Renal Dysfunction Darren Green and Philip A. Kalra |
304 |
30 |
Chronic Lung Disease Michael Greenstone, Simon P Hart, and
Nathaniel M. Hawkins |
313 |
31 |
Pulmonary Hypertension T.J.
Corte and S.J. Wort |
321 |
32 |
Diabetes Mellitus Andrew Jamieson |
329 |
33 |
Valvular Heart Disease Gregory Ducroq, Bernard Lung, and
Alec Vahanian |
340 |
34 |
Sleep-Disordered Breathing Anita K. Simonds |
352 |
35 |
Arthritis Nicola L. Walker and Anne McEntegart |
359 |
36 |
Arrhythmias Ashley M. Nisbet and Derek T.
Connelly |
369 |
PART XI |
MEDICAL THERAPY FOR CHRONIC HEART FAILURE |
|
37 |
Angiotensin Converting Enzyme Inhibitors and Vasodilators Lain Squire and Andrew L. Clark |
385 |
38 |
β-Adrenoreceptor Antagonists and Heart Failure Henry J. Dargie and Desmond Fitzgerald |
392 |
39 |
Aldosterone Antagonists Sushma Rekhraj, Benjamin R. Szwejkowski, and Allan Struthers |
402 |
40 |
Angiotensin Receptor Blockers John J.V. McMurray |
409 |
41 |
Therapeutic Control of Fluid Balance in Chronic Heart Failure Andrew L. Clark, Alison P. Coletta,
and John G.F. Cleland |
419 |
42 |
Digoxin Andrew J.S. Coats |
431 |
43 |
Antithrombotic Agents John G.F. Cleland, Azam Torabi, Jufen Zhang, and Raj K. Chelliah |
437 |
PART XII |
MEDICAL THERAPY FOR ACUTE HEART FAILURE |
|
44 |
Inotropes, Pressors, and Vasodilators Susanna Price and Shahana Uddin |
449 |
PART XIII |
NONPHARMACOLOGICAL MANAGEMENT |
|
45 |
Cardiac Rehabilitation and Chronic Heart Failure Massimo F. Piepoli and Andrew L. Clark |
459 |
46 |
Nonpharmacological Management Lynda Blue and Yvonne Millerick |
469 |
PART XIV |
DEVICE THERAPY FOR HEART FAILURE |
|
47 |
Implantable Cardioverter-Defibrillators in Heart Failure Rachel C. Myles and Derek T.
Connelly |
479 |
48 |
Cardiac Resynchronization Therapy Badrinathan Chandrasekaran and Peter
J. Cowburn |
495 |
PART XV |
SURGICAL THERAPY FOR HEART FAILURE |
|
49 |
Heart Transplantation Nicholas R. Banner, Andre R. Simon,
and Margaret M. Burke |
513 |
50 |
Revascularization and Remodelling Surgery John R. Pepper |
529 |
51 |
Ventricular Assist Devices, Including Intra-Aortic Balloon Pumps Emma J. Birks and Mark S. Slaughter |
537 |
52 |
Mitral Valve Surgery in Heart Failure Andrew Murday |
547 |
PART XVI |
VENTILATORY STRATEGIES IN HEART FAILURE |
|
53 |
Ventilatory Strategies in Acute Heart Failure Mhamed Mebazaa and Alexandre Mebazaa |
553 |
PART XVII |
DISEASE MANAGEMENT |
|
54 |
Multidisciplinary Heart Failure Management Programmes Ali Vazir and Suzanna Hardman |
559 |
55 |
End of Life Miriam Johnson |
568 |
56 |
Monitoring Jillian P. Riley and Martin R.
Cowie |
576 |
PART XVIII |
FUTURE THERAPIES |
|
57 |
The Future Andrew L. Clark, Henry J. Dargie,
Roy S. Gardner, and Theresa A. McDonagh |
587 |
|
Index |
591 |
|
|
|